At 28 weeks after initial treatment, the mice were euthanized by CO 2 inhalation, and the major organs (liver, lung, spleen, kidney and heart) were collected
Zhao, Y
What This GLP-1 Cluster Explains Across this series, youll learn: how GLP-1 works within enteroendocrine and gutbrain signaling why microbiome damage weakens GLP-1 sensitivity how stress and cortisol disrupt appetite regulation how SCFAs restore metabolic flexibility what GLP-1 medications cannot biologically repair Whether GLP-1 medications are used or not, long-term metabolic outcomes depend on the same foundation : A stable microbiome that produces adequate SCFAs and supports natural GLP-1 signaling
Expanding oral GLP-1 options could help many patients access effective treatment who might otherwise never start therapy because they dont want injections
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk
Just this month, on January 29, 2026, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) issued an important update for patients and prescribers